Marylou Ingram, M.D., Senior Research Scientist, and Director, In Vitro Systems/Tissue Engineering, Huntington Medical Research Institutes, Pasadena, CA

PodcastsResourcesCancersGenetic engineeringGenetic Engineering and BiotechnologyMedicine, Diagnosis, and TherapeuticsRegenerative engineeringSystemic conditionsTissue engineeringTumors
Previous articleAutoGenomics Granted FDA Approval for Infiniti CYP2C19 Assay
Next articlePilot Phase of 1000 Genomes Project Identifies 8 Million New Genetic Variants